TRELLIS BIOSCIENCE

The immune system is nature's most powerful weapon against disease. Trellis Bioscience is an NIH and venture-funded biotechnology company that leverages its proprietary CellSpot™ technology to derive rare, naturally optimized antibodies from healthy donor blood against infectious diseases and cancer... Our management team possesses diverse experience across academic, biotechnology, pharmaceutical, and venture capital industries... We are business leaders and scientists passionate about developing human antibody therapies to various diseases.

Primary location: Redwood City United States